狂怒
发表于 2025-3-27 00:24:27
Metabolomic Role in Personalized Medicine: An Update,ethod to provide the theoretical basis for individualized medical treatment. This chapter overviews clinical metabotyping, disease biomarker discovery, and pharmacometabolomics toward personalized medicine, improving drug efficacy. These three approaches enhance the understanding of the disease’s pa
tinnitus
发表于 2025-3-27 04:52:28
http://reply.papertrans.cn/23/2281/228084/228084_32.png
爱哭
发表于 2025-3-27 08:19:44
http://reply.papertrans.cn/23/2281/228084/228084_33.png
热情的我
发表于 2025-3-27 11:38:57
http://reply.papertrans.cn/23/2281/228084/228084_34.png
coltish
发表于 2025-3-27 14:40:55
https://doi.org/10.1007/978-3-658-11366-7cal system. Targeted and quantitative MS-based assays containing relatively large panels of small molecules (metabolites) are routinely utilized for newborn screening (NBS), biochemical genetics testing, and toxicology. Broad nontargeted metabolomics investigations have found some utility in the afo
沙漠
发表于 2025-3-27 20:37:28
http://reply.papertrans.cn/23/2281/228084/228084_36.png
DAMP
发表于 2025-3-28 01:24:03
http://reply.papertrans.cn/23/2281/228084/228084_37.png
使更活跃
发表于 2025-3-28 02:48:19
Lothar Brock,Egbert Jahn,Reiner Steinwegpatient outcomes. Breaking the diagnostic barrier can mean new research, new drugs, and ultimately increased survival. In this chapter, we overview the concept of untargeted metabolomics as applied to newborn screening, how it fares compared to the well-standardized tests of the targeted screening,
容易懂得
发表于 2025-3-28 08:46:24
https://doi.org/10.1007/978-3-322-86202-0Ds can appear over the entire life span. Patients with particular MDs present a wide range of heterogeneous phenotypes with different levels of disease severity. The wide variety of leading causes and heterogenous phenotypes of MDs make diagnosing MDs notoriously challenging. Despite these challenge
门闩
发表于 2025-3-28 11:55:23
https://doi.org/10.1007/978-3-322-86202-0bolomic analysis techniques in pituitary disease will be a helpful clinical tool for significantly improving diagnosis and, potentially, the therapeutic approach by identifying highly specific disease biomarkers and novel molecular pathogenic mechanisms.